TCIM
GNCA
TIAA CREF Investment Management’s Genocea Biosciences, Inc. GNCA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-263,874
| Closed | -$277K | – | 3172 |
|
|
2018
Q1 | $277K | Buy |
263,874
+159,800
| +154% | +$168K | ﹤0.01% | 2919 |
|
|
2017
Q4 | $121K | Buy |
104,074
+24,692
| +31% | +$28.7K | ﹤0.01% | 3034 |
|
|
2017
Q3 | $116K | Buy |
79,382
+1,902
| +2% | +$2.78K | ﹤0.01% | 3064 |
|
|
2017
Q2 | $404K | Buy |
+77,480
| New | +$404K | ﹤0.01% | 2956 |
|
|
2016
Q2 | – | Sell |
-64,090
| Closed | -$496K | – | 3224 |
|
|
2016
Q1 | $496K | Sell |
64,090
-74,898
| -54% | -$580K | ﹤0.01% | 2790 |
|
|
2015
Q4 | $732K | Buy |
138,988
+45,643
| +49% | +$240K | ﹤0.01% | 2758 |
|
|
2015
Q3 | $639K | Buy |
93,345
+32,391
| +53% | +$222K | ﹤0.01% | 2808 |
|
|
2015
Q2 | $837K | Buy |
60,954
+46,374
| +318% | +$637K | ﹤0.01% | 2781 |
|
|
2015
Q1 | $173K | Hold |
14,580
| – | – | ﹤0.01% | 3069 |
|
|
2014
Q4 | $102K | Sell |
14,580
-783
| -5% | -$5.48K | ﹤0.01% | 3117 |
|
|
2014
Q3 | $139K | Hold |
15,363
| – | – | ﹤0.01% | 3098 |
|
|
2014
Q2 | $288K | Buy |
15,363
+11,133
| +263% | +$209K | ﹤0.01% | 3069 |
|
|
2014
Q1 | $77K | Buy |
+4,230
| New | +$77K | ﹤0.01% | 3112 |
|